Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prime Medicine, Inc.

2.00
+0.240013.64%
Post-market: 2.010.0100+0.50%19:53 EDT
Volume:1.95M
Turnover:3.79M
Market Cap:255.33M
PE:-1.21
High:2.06
Open:1.77
Low:1.77
Close:1.76
Loading ...

Prime Medicine, Inc.: Promising Future in Gene Editing with Innovative AATD Program and Strategic Growth Potential

TIPRANKS
·
Yesterday

Prime Medicine Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Yesterday

Prime Medicine, Inc.: Innovative Prime Editing Technology and Promising Preclinical Results Drive Buy Rating

TIPRANKS
·
Yesterday

Wedbush Adjusts Prime Medicine Price Target to $13 From $12, Maintains Outperform Rating

MT Newswires Live
·
Yesterday

BRIEF-Prime Medicine Unveils Program For The Treatment Of Alpha-1 Antitrypsin Deficiency (AATD)

Reuters
·
18 Mar

Prime Medicine Price Target Maintained With a $10.00/Share by Citizens Capital Markets

Dow Jones
·
04 Mar

Prime Medicine Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Mar

Prime Medicine Is Maintained at Buy by Chardan Capital

Dow Jones
·
03 Mar

TD Cowen Sticks to Its Buy Rating for Prime Medicine, Inc. (PRME)

TIPRANKS
·
28 Feb

Prime Medicine reports FY24 EPS ($1.65) vs ($2.18) last year

TIPRANKS
·
28 Feb

Prime Medicine FY 2024 GAAP EPS $(1.65) Beats $(1.66) Estimate, Sales $2.983M Beats $929.100K Estimate

Benzinga
·
28 Feb

Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates

GlobeNewswire
·
28 Feb

Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
24 Feb

Prime Drink Group Announces The Appointment Of A New Chief Financial Officer

T-Reuters
·
14 Jan

Is Prime Medicine (PRME) Among the Top CRISPR Stocks to Invest In?

Insider Monkey
·
01 Jan

Why Prime Medicine (PRME) Is One of the Best Biotech Penny Stocks to Invest in Now?

Insider Monkey
·
31 Dec 2024